Proposed mechanism by which PRL may affect CPT1 enzyme activity in breast cancer cells

Proposed mechanism by which PRL may affect CPT1 enzyme activity in breast cancer cells. PRL signaling may alter CPT1 enzyme activity in two distinct manners, with potential cross-talk. In 1), PRL mediates its effect through LKB1, resulting in activation of the AMPK pathway via phosphorylation of AMPKα at Thr172 (pAMPKα) and inactivation of ACC (pACC), culminating in increased CPT1 enzyme activity. In 2), PRL either directly, or indirectly through the activation of AMPK, induces PPARα to increase CPT1A expression, resulting in changes at both the mRNA and protein levels, thereby increasing CPT1 enzyme activity. Dashed arrows and ?s indicate components of the pathway(s) that remain to be conclusively established.
Proposed mechanism by which PRL may affect CPT1 enzyme activity in breast cancer cells

Publication

Establishing a relationship between prolactin and altered fatty acid β-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells. (2011) Katja Linher-Melville, et al. BMC Cancer. 2011;11:56-56. Figure: F8.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates LKB1 LKB1 ncbigene_synonym STK11 6794
Homo sapiens Primates CPT1 CPT1 ncbigene_synonym CPT1A 1374
Homo sapiens Primates CPT1 CPT1 ncbigene_synonym CPT2 1376
Homo sapiens Primates CPT1 CPT1 ncbigene_synonym CHPT1 56994
Homo sapiens Primates PPARA PPARA ncbigene_symbol PPARA 5465
Homo sapiens Primates ↑ATP? ATP ncbigene_synonym ATP8A2 51761
Homo sapiens Primates PRLR PRLR ncbigene_symbol PRLR 5618
Homo sapiens Primates PRLR PRLR ncbigene_synonym PTP4A3 11156

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID